Elastographic parameters of liver steatosis and fibrosis predict independently the risk of incident chronic kidney disease and acute myocardial infarction in patients with type 2 diabetes mellitus

Accuracy of Controlled Attenuation Parameter and Liver Stiffness Measurement in Patients with Non-alcoholic Fatty Liver Disease

(2021) Ivana Mikolasevic et al.   ULTRASOUND IN MEDICINE AND BIOLOGY

Significant liver fibrosis, as assessed by fibroscan, is independently associated with chronic vascular complications of type 2 diabetes: A multicenter study

(2021) I. Mikolasevic et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Prognostic impact of liver fibrosis and steatosis by transient elastography for cardiovascular and mortality outcomes in individuals with nonalcoholic fatty liver disease and type 2 diabetes: the Rio de Janeiro Cohort Study

(2021) Claudia R. L. Cardoso et al.   Cardiovascular Diabetology

Advanced fibrosis is associated with incident cardiovascular disease in patients with non-alcoholic fatty liver disease

(2020) Jacqueline B. Henson et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Association Between Fibrosis Stage and Outcomes of Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis

(2020) Rod S. Taylor et al.   GASTROENTEROLOGY

Natural History of Nonalcoholic Fatty Liver Disease: Implications for Clinical Practice and an Individualized Approach

(2020) Ivica Grgurevic et al.   Canadian Journal of Gastroenterology and Hepatology

FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study

(2020) Philip N Newsome et al.   Lancet Gastroenterology & Hepatology

NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications

(2020) Giovanni Targher et al.   GUT

Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

(2019) Peter J. Eddowes et al.   GASTROENTEROLOGY

Obesity, Metabolic Syndrome and the Risk of Microvascular Complications in Patients with Diabetes Mellitus

(2019) Niki Katsiki et al.   CURRENT PHARMACEUTICAL DESIGN

Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease

(2019) Andrew A. Li et al.   Gut and Liver

Nonalcoholic Fatty Liver Disease and the Incidence of Myocardial Infarction: A Cohort Study

(2019) Dong Hyun Sinn et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Liver fibrosis by FibroScan ® independently of established cardiovascular risk parameters associates with macrovascular and microvascular complications in patients with type 2 diabetes

(2019) Rosa Lombardi et al.   LIVER INTERNATIONAL

Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease

(2018) Eduardo Vilar-Gomez et al.   GASTROENTEROLOGY

Non-alcoholic fatty liver disease: a pandemic disease with multisystem burden

(2018) Somaya Albhaisi et al.   HEPATOBILIARY SURGERY AND NUTRITION

Non-alcoholic fatty liver disease – A global public health perspective

(2018) Zobair M. Younossi   JOURNAL OF HEPATOLOGY

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

(2017) Naga Chalasani et al.   HEPATOLOGY

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

(2016)   JOURNAL OF HEPATOLOGY

Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis

(2016) Giovanni Targher et al.   JOURNAL OF HEPATOLOGY

Non-alcoholic fatty liver disease and risk of cardiovascular disease

(2016) Amedeo Lonardo et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Nonalcoholic fatty liver disease - A multisystem disease?

(2016) Ivana Mikolasevic et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Non-Alcoholic Fatty Liver Disease Proven by Transient Elastography in Hemodialysis Patients: Is It a New Risk Factor for Adverse Cardiovascular Events?

(2014) Ivana Mikolasevic et al.   BLOOD PURIFICATION

Nonalcoholic Fatty Liver Disease (NAFLD) And Cardiovascular Risk In Renal Transplant Recipients

(2014) Ivana Mikolasevic et al.   KIDNEY & BLOOD PRESSURE RESEARCH

Nonalcoholic fatty liver disease (NAFLD) proven by transient elastography in patients with coronary heart disease

(2014) Ivana Mikolasevic et al.   WIENER KLINISCHE WOCHENSCHRIFT

Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis

(2014) Giovanni Musso et al.   PLOS MEDICINE

Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease - the role of transient elastography and plasma cytokeratin-18 fragments

(2013) R. Kwok et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

A New Equation to Estimate Glomerular Filtration Rate

(2013) Andrew S. Levey et al.   ANNALS OF INTERNAL MEDICINE

Liver Stiffness Measurement Using XL Probe in Patients With Nonalcoholic Fatty Liver Disease

(2012) Vincent Wai-Sun Wong et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Relationship between Kidney Function and Liver Histology in Subjects with Nonalcoholic Steatohepatitis

(2010) G. Targher et al.   Clinical Journal of the American Society of Nephrology

Nonalcoholic steatohepatitis and increased risk of chronic kidney disease

(2010) Kohichiroh Yasui et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Controlled Attenuation Parameter (CAP): A Novel VCTE™ Guided Ultrasonic Attenuation Measurement for the Evaluation of Hepatic Steatosis: Preliminary Study and Validation in a Cohort of Patients with Chronic Liver Disease from Various Causes

(2010) Magali Sasso et al.   ULTRASOUND IN MEDICINE AND BIOLOGY

Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease

(2009) Vincent Wai-Sun Wong et al.   HEPATOLOGY